Riva Therapeutics
Pre-clinicalRiva Therapeutics is a precision oncology company focused on creating transformative medicines for cancer patients. We are developing a new generation of small molecule therapeutics by leveraging deep knowledge of genomic dependencies to selectively target essential tumor cell processes beyond DNA damage repair. Our precision lethal therapies have the potential to provide profound clinical activity, be well-tolerated, and substantially improve patient lives.
About
Riva Therapeutics is a precision oncology company focused on creating transformative medicines for cancer patients. We are developing a new generation of small molecule therapeutics by leveraging deep knowledge of genomic dependencies to selectively target essential tumor cell processes beyond DNA damage repair. Our precision lethal therapies have the potential to provide profound clinical activity, be well-tolerated, and substantially improve patient lives.
Funding History
2Total raised: $67M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile